Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

By Waitzinger J.  

Clinical Drug Investigation, Vol. 16, Iss. 2, 1998-08 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite

Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers

By Waitzinger J.  

Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. : 119-125

Adis International

Access to resources Recommend Favorite

Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats

By Leuschner J.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 331-338

Adis International

Access to resources Recommend Favorite

Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers: Safety and Pharmacokinetics of Single or Multiple Intravenous Infusions

By Li Hao  

Drugs in R&D, Vol. 12, Iss. 2, 2012-06 ,pp. : 65-70

Adis International

Access to resources Recommend Favorite

A Phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers

By Lee Hae Won   Lim Mi-sun   Seong Sook Jin   Lee Joomi   Park Jeonghyeon   Seo Jeong Ju   Yun Hwi-yeol   Baek In-hwan   Kwon Kwang-il   Yoon Young-Ran  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1471-1479

Informa Healthcare

Access to resources Recommend Favorite